Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
暂无分享,去创建一个
B. Karlan | P. Møller | C. Isaacs | J. Lubiński | S. Neuhausen | B. Rosen | S. Narod | J. Kotsopoulos | H. Lynch | P. Ainsworth | P. Sun | P. Ghadirian